HCPCS codes

22721 HCPCS codes with hospital pricing data in the network.

• HCPCS J2426 — Paliperidone palmitate extended-release injection, per 1 mgAI (1752 hospitals, 3,825–4,635 samples)
• HCPCS C9046 — Cocaine nasal solution (Goprelto), 1 mgAI (1423 hospitals, 1,902–4,611 samples)
• HCPCS Q4196 — PuraPly wound covering, 1 square centimeterAI (2002 hospitals, 1,191–4,575 samples)
• HCPCS Q0177 — Hydroxyzine pamoate 25 mg oral capsuleAI (1174 hospitals, 1,935–4,527 samples)
• HCPCS J0713 — Ceftazidime injection, 2 gram IVAI (2248 hospitals, 820–4,519 samples)
• HCPCS A6222 — Sterile gauze pad, 16 sq. in. or less, medicated dressingAI (860 hospitals, 852–4,506 samples)
• HCPCS L0625 — Flexible off-the-shelf lower back braceAI (1397 hospitals, 745–4,498 samples)
• HCPCS J0457 — Aztreonam injection, 1 gramAI (2120 hospitals, 888–4,443 samples)
• HCPCS C1878 — Calcium hydroxylapatite voice implant, 1.5 ccAI (1333 hospitals, 571–4,423 samples)
• HCPCS J0175 — Donanemab drug injection, 2 mg unitAI (1346 hospitals, 4,181–4,415 samples)
• HCPCS J0168 — Epinephrine injection, 0.1 mg, prefilled syringeAI (1300 hospitals, 2,320–4,372 samples)
• HCPCS J0896 — Luspatercept injection, 0.25 mgAI (1722 hospitals, 2,870–4,292 samples)
• HCPCS Q0169 — Promethazine 25 mg oral tabletAI (1517 hospitals, 604–4,285 samples)
• HCPCS Q4158 — Marigen wound dressing, 1 square cmAI (1662 hospitals, 1,392–4,209 samples)
• HCPCS G0447 — Behavioral counseling for obesity, 15 minutesAI (1133 hospitals, 2,409–4,209 samples)
• HCPCS Q2009 — Fosphenytoin sodium injectionAI (2216 hospitals, 594–4,194 samples)
• HCPCS Q5105 — Retacrit (epoetin alfa biosimilar) 10,000 units for dialysis patientsAI (1493 hospitals, 747–4,194 samples)
• HCPCS J1170 — Hydromorphone injection, 2 mg per mLAI (1014 hospitals, 3,202–4,192 samples)
• HCPCS J7185 — Factor VIII injection (recombinant), billed per international unitAI (1345 hospitals, 3,940–4,174 samples)
• HCPCS A6210 — Foam dressing, non-adhesive, 6 by 6 inchesAI (984 hospitals, 547–4,156 samples)
• HCPCS G0299 — Hospice registered nurse visit, per 15 minutesAI (392 hospitals, 3,855–4,152 samples)
• HCPCS J7201 — Alprolix factor IX injection, per international unitAI (1203 hospitals, 4,110 samples)
• HCPCS Q4433 — Skin substitute product, not otherwise specifiedAI (536 hospitals, 1,151–4,040 samples)
• HCPCS S9443 — LACTATION CLASSAI (680 hospitals, 2,793–4,026 samples)
• HCPCS G0557 — Advanced primary care management for multiple chronic conditionsAI (747 hospitals, 3,969–4,014 samples)
• HCPCS J9130 — Dacarbazine injection, 100 mgAI (1936 hospitals, 2,307–4,008 samples)
• HCPCS G0476 — High-risk HPV DNA test for cervical cancer screeningAI (1318 hospitals, 2,837–3,989 samples)
• HCPCS L3923 — Prefabricated hand-finger orthosis without jointsAI (1576 hospitals, 544–3,955 samples)
• HCPCS J1447 — Tbo-filgrastim 480 mcg injectionAI (1868 hospitals, 2,150–3,941 samples)
• HCPCS Q9950 — Sulfur hexafluoride lipid microsphere injection, per milliliterAI (1435 hospitals, 2,055–3,927 samples)
• HCPCS J1073 — Testosterone pellet, implant, 75 mgAI (465 hospitals, 3,903–3,921 samples)
• HCPCS A9592 — Copper Cu-64 dotatate diagnostic imaging agent, 1 millicurieAI (1397 hospitals, 760–3,919 samples)
• HCPCS J1120 — Acetazolamide sodium injection 500 mgAI (2231 hospitals, 846–3,888 samples)
• HCPCS J3247 — Secukinumab intravenous injection, per mgAI (1433 hospitals, 3,336–3,840 samples)
• HCPCS V5299 — HEARING SERVICEAI (356 hospitals, 382–3,820 samples)
• HCPCS A6021 — Puracol collagen dressing, 1 x 8 inchAI (1041 hospitals, 775–3,799 samples)
• HCPCS S0302 — Completed children's preventive screening form (EPSDT)AI (277 hospitals, 3,539–3,791 samples)
• HCPCS J8498 — Anti-nausea suppository, not otherwise specifiedAI (474 hospitals, 379–3,790 samples)
• HCPCS J3055 — Talquetamab injection, 0.25 mgAI (1393 hospitals, 3,576–3,783 samples)
• HCPCS H0001 — Alcohol and drug use assessmentAI (416 hospitals, 1,396–3,754 samples)
• HCPCS T1013 — Sign language or oral interpreter servicesAI (374 hospitals, 3,701–3,746 samples)
• HCPCS J7300 — Intrauterine copper contraceptive deviceAI (1560 hospitals, 707–3,722 samples)
• HCPCS C1831 — Expandable spine fusion spacer, 26x45 mmAI (483 hospitals, 371–3,710 samples)
• HCPCS L1902 — Ankle-foot orthosis, pre-fabricated gauntlet styleAI (1502 hospitals, 863–3,698 samples)
• HCPCS J0573 — Buprenorphine and naloxone oral tablet, 3 to 6 mgAI (1022 hospitals, 369–3,690 samples)
• HCPCS J2356 — Injection of tezepelumab-ekko, per 1 mgAI (1625 hospitals, 2,916–3,663 samples)
• HCPCS J1930 — Lanreotide injection, per 1 mgAI (1719 hospitals, 1,734–3,642 samples)
• HCPCS A9576 — Gadoteridol contrast injection (ProHance multipack), per milliliterAI (1222 hospitals, 3,423–3,621 samples)
• HCPCS J0595 — Butorphanol 2 mg injectionAI (2002 hospitals, 627–3,579 samples)
• HCPCS J1921 — Injection of labetalol hydrochloride, 5 mgAI (1297 hospitals, 1,178–3,545 samples)